Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Respiratory admittance measurement for diagnosis of childhood asthma
2007-002822-31Phase 4Active
- Sponsor
- CHRU Nancy
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of salbutamol in asthma (2 arms), sponsored by CHRU Nancy. Primary endpoint: Respiratory admittance measurement. Started Aug 2007; status: active.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on 2007-002822-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002822-31.